Merck (MRK) Cash from Financing Activities (2009 - 2026)

Merck (MRK) has 18 years of Cash from Financing Activities data on file, last reported at -$3.0 billion in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$3.0 billion, up 48.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $852.0 million (up 108.54% YoY), and the FY2025 annual result was -$1.9 billion, up 72.67% from the prior year.
• Cash from Financing Activities fell to -$3.0 billion in Q1 2026 per MRK's latest filing, from $4.8 billion in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $4.8 billion in Q4 2025 and troughed at -$5.8 billion in Q1 2025.
• A 5-year average of -$1.5 billion and a median of -$2.4 billion in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 311.48% in 2023, then plunged 392.43% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$1.6 billion in 2022, then tumbled by 44.47% to -$2.2 billion in 2023, then sank by 34.03% to -$3.0 billion in 2024, then surged by 257.89% to $4.8 billion in 2025, then sank by 162.74% to -$3.0 billion in 2026.
• Business Quant data shows MRK's Cash from Financing Activities at -$3.0 billion in Q1 2026, $4.8 billion in Q4 2025, and $2.6 billion in Q3 2025.